These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21625163)

  • 41. Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer.
    Lin JC; Jen YM; Li MH; Chao HL; Tsai JT
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):259-64. PubMed ID: 25629569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States.
    Daly ME; Perks JR; Chen AM
    J Thorac Oncol; 2013 Feb; 8(2):202-7. PubMed ID: 23222368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re-irradiation for painful bone metastases using stereotactic body radiotherapy.
    Ogawa H; Ito K; Shimizuguchi T; Furuya T; Nihei K; Karasawa K
    Acta Oncol; 2018 Dec; 57(12):1700-1704. PubMed ID: 30280622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
    J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging technologies in stereotactic body radiotherapy.
    Ma L; Wang L; Tseng CL; Sahgal A
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S12. PubMed ID: 28917250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
    Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
    BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
    Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
    Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Doi H; Beppu N; Kitajima K; Kuribayashi K
    Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
    Aneja S; Yu JB
    Semin Radiat Oncol; 2014 Jan; 24(1):35-42. PubMed ID: 24314340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
    Ahmed KA; Torres-Roca JF
    Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The radiobiological targets of SBRT: tumor cells or endothelial cells?
    Karam SD; Bhatia S
    Ann Transl Med; 2015 Nov; 3(19):290. PubMed ID: 26697450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
    Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
    World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
    Teh BS; Ishiyama H; Mathews T; Xu B; Butler EB; Mayr NA; Lo SS; Lu JJ; Blanco AI; Paulino AC; Timmerman RD
    Discov Med; 2010 Sep; 10(52):255-62. PubMed ID: 20875347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer.
    Koay EJ; Hall W; Park PC; Erickson B; Herman JM
    Abdom Radiol (NY); 2018 Feb; 43(2):393-403. PubMed ID: 29110053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
    Kroeze SGC; Pavic M; Stellamans K; Lievens Y; Becherini C; Scorsetti M; Alongi F; Ricardi U; Jereczek-Fossa BA; Westhoff P; But-Hadzic J; Widder J; Geets X; Bral S; Lambrecht M; Billiet C; Sirak I; Ramella S; Giovanni Battista I; Benavente S; Zapatero A; Romero F; Zilli T; Khanfir K; Hemmatazad H; de Bari B; Klass DN; Adnan S; Peulen H; Salinas Ramos J; Strijbos M; Popat S; Ost P; Guckenberger M
    Lancet Oncol; 2023 Mar; 24(3):e121-e132. PubMed ID: 36858728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.
    Johnson SB; Soulos PR; Shafman TD; Mantz CA; Dosoretz AP; Ross R; Finkelstein SE; Collins SP; Suy S; Brower JV; Ritter MA; King CR; Kupelian PA; Horwitz EM; Pollack A; Abramowitz MC; Hallman MA; Faria S; Gross CP; Yu JB
    Radiother Oncol; 2016 Nov; 121(2):294-298. PubMed ID: 27890426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings.
    Khrizman P; Small W; Dawson L; Benson AB
    Clin Colorectal Cancer; 2010 Jul; 9(3):136-43. PubMed ID: 20643617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.
    Conde-Moreno AJ; Lopez-Guerra JL; Macias VA; Vázquez de la Torre ML; Samper Ots P; San José-Maderuelo S; Pastor Peidro J; López-Torrecilla J; Expósito-Hernández J
    Clin Transl Oncol; 2016 Apr; 18(4):342-51. PubMed ID: 26329294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
    Siva S; MacManus M; Ball D
    J Thorac Oncol; 2010 Jul; 5(7):1091-9. PubMed ID: 20479693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.
    Song DY; Kavanagh BD; Benedict SH; Schefter T
    Oncology (Williston Park); 2004 Oct; 18(11):1419-30; discussion 1430, 1432, 1435-6. PubMed ID: 15609470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.